163 related articles for article (PubMed ID: 8116248)
1. Poliovirus type 3/Saukett: antigenic and structural correlates of sequence variation in the capsid proteins.
Huovilainen A; Kinnunen L; Pöyry T; Laaksonen L; Roivainen M; Hovi T
Virology; 1994 Feb; 199(1):228-32. PubMed ID: 8116248
[TBL] [Abstract][Full Text] [Related]
2. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
Friedrich F; Da-Silva EF; Schatzmayr HG
Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
[TBL] [Abstract][Full Text] [Related]
3. Determination of antigenic properties of vaccine derived poliovirus strains.
Pliaka V; Achilleos C; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonica C; Levidiotou-Stefanou S; Markoulatos P
Vaccine; 2010 Dec; 29(1):26-33. PubMed ID: 20974307
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a recombinant type 3/type 2 poliovirus with a chimeric capsid VP1 from sewage in Shandong, China.
Tao Z; Wang H; Xu A; Zhang Y; Song L; Zhu S; Li Y; Yan D; Liu G; Yoshida H; Liu Y; Feng L; Chosa T; Xu W
Virus Res; 2010 Jun; 150(1-2):56-60. PubMed ID: 20206214
[TBL] [Abstract][Full Text] [Related]
5. Partial RNA sequencing of eight supposed derivatives of type 3 poliovirus/USA/Saukett/50 reveals remarkable differences between three apparent substrains.
Kinnunen L; Hovi T
Virology; 1989 May; 170(1):316-20. PubMed ID: 2541551
[TBL] [Abstract][Full Text] [Related]
6. Antigenic variation among 173 strains of type 3 poliovirus isolated in Finland during the 1984 to 1985 outbreak.
Huovilainen A; Kinnunen L; Ferguson M; Hovi T
J Gen Virol; 1988 Aug; 69 ( Pt 8)():1941-8. PubMed ID: 2841408
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide sequences of the VP1 capsid proteins of wild poliovirus types 1 and 3 from epidemic areas of Brazil.
Da-Silva EE; Schatzmayr HG; Kew OM
Braz J Med Biol Res; 1990; 23(1):1-5. PubMed ID: 2167137
[TBL] [Abstract][Full Text] [Related]
8. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid.
Strassheim ML; Gruenberg A; Veijalainen P; Sgro JY; Parrish CR
Virology; 1994 Jan; 198(1):175-84. PubMed ID: 8259653
[TBL] [Abstract][Full Text] [Related]
9. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants.
Huovilainen A; Hovi T; Kinnunen L; Takkinen K; Ferguson M; Minor P
J Gen Virol; 1987 May; 68 ( Pt 5)():1373-8. PubMed ID: 2437244
[TBL] [Abstract][Full Text] [Related]
10. Potential use of poliovirus as a vector.
Girard M; Martin A; van der Werf S
Biologicals; 1993 Dec; 21(4):371-7. PubMed ID: 8024753
[TBL] [Abstract][Full Text] [Related]
11. Genetic and antigenic analysis of type A foot-and-mouth disease viruses isolated in India during 1987-1996.
Nayak B; Pattnaik B; Tosh C; Sanyal A; Hemadri D; Patil SS; Venkataramanan R
Acta Virol; 2001 Feb; 45(1):13-21. PubMed ID: 11394573
[TBL] [Abstract][Full Text] [Related]
12. [Antigen differences of genetic variants Abent+ and Abent- poliovirus vaccine strain of III type].
Shyrobokov VP; Kostenko IH; Nikolaienko IV
Mikrobiol Z; 2003; 65(4):29-36. PubMed ID: 14618784
[TBL] [Abstract][Full Text] [Related]
13. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor.
Harber J; Bernhardt G; Lu HH; Sgro JY; Wimmer E
Virology; 1995 Dec; 214(2):559-70. PubMed ID: 8553558
[TBL] [Abstract][Full Text] [Related]
14. Antigenic sites on type 2 poliovirus.
Patel V; Ferguson M; Minor PD
Virology; 1993 Jan; 192(1):361-4. PubMed ID: 7685967
[TBL] [Abstract][Full Text] [Related]
15. Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1.
Blomqvist S; Savolainen-Kopra C; Paananen A; El Bassioni L; El Maamoon Nasr EM; Firstova L; Zamiatina N; Kutateladze T; Roivainen M
Virus Res; 2010 Aug; 151(2):246-51. PubMed ID: 20493912
[TBL] [Abstract][Full Text] [Related]
16. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Schild GC
Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.
Blomqvist S; Bruu AL; Stenvik M; Hovi T
J Gen Virol; 2003 Mar; 84(Pt 3):573-580. PubMed ID: 12604808
[TBL] [Abstract][Full Text] [Related]
18. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
[TBL] [Abstract][Full Text] [Related]
19. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
Macadam AJ; Pollard SR; Ferguson G; Skuce R; Wood D; Almond JW; Minor PD
Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
[TBL] [Abstract][Full Text] [Related]
20. Mapping of antigenic domains in poliovirus VP1 involved in structural rearrangements during virus morphogenesis and antigenic alterations of the virion.
Ketterlinus R; Wiegers K
Virology; 1994 Oct; 204(1):27-37. PubMed ID: 7522372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
